Clinical Trials Directory

Trials / Completed

CompletedNCT05251623

Walking Program With Pedometer on Quality of Life in COPD

The Effect of Walking Program With Pedometer on Quality-of-life Among Chronic Obstructive Pulmonary Disease Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
45 (actual)
Sponsor
Chang Gung University · Academic / Other
Sex
All
Age
40 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to investigate the effects of a walking program on exercise capacity and quality of life in patient with COPD. Method: Patients with COPD were randomly assigned to pedometer group (PG) or control group (CON). Subjects in PG walked to target steps daily with pedometer for 6 weeks. Before and after the program, the following measurements were performed: pulmonary function test (PFT), daily steps, Six-Minute Walk Test (6MWT), COPD Assessment Test (CAT), and quality of life questionnaire (SF-12).

Detailed description

Patients with chronic obstructive pulmonary disease (COPD) are suffered from impaired pulmonary function and dyspnea which result to limited level of physical activity, and impaired quality of life. Exercise and regular physical activity have been proven to break the vicious circle. The aim of this study is to investigate the effects of a walking program on exercise capacity and quality of life in patient with COPD. Method: Patients with COPD were randomly assigned to pedometer group (PG) or control group (CON). Subjects in PG walked to target steps daily with pedometer for 6 weeks. Before and after the program, the pulmonary function was assessed by spiromtery test. The exercise capacity were assessed by six-minute walking test, the physical activity level was assessed by daily steps, The quality of life was assessed by COPD Assessment Test (CAT), and quality of life questionnaire (SF-12). .

Conditions

Interventions

TypeNameDescription
OTHERwalking programSubjects in PG walked to target steps daily with pedometer for 6 weeks

Timeline

Start date
2018-03-01
Primary completion
2018-03-31
Completion
2019-03-31
First posted
2022-02-23
Last updated
2022-02-23

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT05251623. Inclusion in this directory is not an endorsement.